Global RhEPO Market Research Report 2021

1 rhEPO Market Overview
1.1 Product Overview and Scope of rhEPO
1.2 rhEPO Segment by Type
1.2.1 Global rhEPO Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 ESRD
1.2.3 Cancer
1.2.4 HIV
1.2.5 Wounds and neural disease
1.3 rhEPO Segment by Application
1.3.1 rhEPO Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Retail Pharmacies
1.4 Global rhEPO Market Size Estimates and Forecasts
1.4.1 Global rhEPO Revenue 2016-2027
1.4.2 Global rhEPO Sales 2016-2027
1.4.3 rhEPO Market Size by Region: 2016 Versus 2021 Versus 2027

2 rhEPO Market Competition by Manufacturers
2.1 Global rhEPO Sales Market Share by Manufacturers (2016-2021)
2.2 Global rhEPO Revenue Market Share by Manufacturers (2016-2021)
2.3 Global rhEPO Average Price by Manufacturers (2016-2021)
2.4 Manufacturers rhEPO Manufacturing Sites, Area Served, Product Type
2.5 rhEPO Market Competitive Situation and Trends
2.5.1 rhEPO Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest rhEPO Players Market Share by Revenue
2.5.3 Global rhEPO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 rhEPO Retrospective Market Scenario by Region
3.1 Global rhEPO Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global rhEPO Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America rhEPO Market Facts & Figures by Country
3.3.1 North America rhEPO Sales by Country
3.3.2 North America rhEPO Revenue by Country
3.3.3 United States
3.3.4 Canada
3.3.3 Mexico
3.4 Europe rhEPO Market Facts & Figures by Country
3.4.1 Europe rhEPO Sales by Country
3.4.2 Europe rhEPO Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 UK
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific rhEPO Market Facts & Figures by Region
3.5.1 Asia Pacific rhEPO Sales by Region
3.5.2 Asia Pacific rhEPO Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Indonesia
3.5.9 Thailand
3.5.10 Malaysia
3.5.11 Philippines
3.5.12 Vietnam
3.6 Latin America rhEPO Market Facts & Figures by Country
3.6.1 Latin America rhEPO Sales by Country
3.6.2 Latin America rhEPO Revenue by Country
3.6.3 Brazil
3.7 Middle East and Africa rhEPO Market Facts & Figures by Country
3.7.1 Middle East and Africa rhEPO Sales by Country
3.7.2 Middle East and Africa rhEPO Revenue by Country
3.7.3 Turkey
3.7.4 GCC Countries
3.7.5 Egypt
3.7.6 South Africa
4 Global rhEPO Historic Market Analysis by Type
4.1 Global rhEPO Sales Market Share by Type (2016-2021)
4.2 Global rhEPO Revenue Market Share by Type (2016-2021)
4.3 Global rhEPO Price by Type (2016-2021)

5 Global rhEPO Historic Market Analysis by Application
5.1 Global rhEPO Sales Market Share by Application (2016-2021)
5.2 Global rhEPO Revenue Market Share by Application (2016-2021)
5.3 Global rhEPO Price by Application (2016-2021)

6 Key Companies Profiled
6.1 3SBio
6.1.1 3SBio Corporation Information
6.1.2 3SBio Description and Business Overview
6.1.3 3SBio rhEPO Sales, Revenue and Gross Margin (2016-2021)
6.1.4 3SBio Product Portfolio
6.1.5 3SBio Recent Developments/Updates
6.2 Shanghai Chemo
6.2.1 Shanghai Chemo Corporation Information
6.2.2 Shanghai Chemo Description and Business Overview
6.2.3 Shanghai Chemo rhEPO Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Shanghai Chemo Product Portfolio
6.2.5 Shanghai Chemo Recent Developments/Updates
6.3 Chengdu Diao
6.3.1 Chengdu Diao Corporation Information
6.3.2 Chengdu Diao Description and Business Overview
6.3.3 Chengdu Diao rhEPO Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Chengdu Diao Product Portfolio
6.3.5 Chengdu Diao Recent Developments/Updates
6.4 NCPC Genetech
6.4.1 NCPC Genetech Corporation Information
6.4.2 NCPC Genetech Description and Business Overview
6.4.3 NCPC Genetech rhEPO Sales, Revenue and Gross Margin (2016-2021)
6.4.4 NCPC Genetech Product Portfolio
6.4.5 NCPC Genetech Recent Developments/Updates
6.5 Kyowa Hakko Kirin
6.5.1 Kyowa Hakko Kirin Corporation Information
6.5.2 Kyowa Hakko Kirin Description and Business Overview
6.5.3 Kyowa Hakko Kirin rhEPO Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Kyowa Hakko Kirin Product Portfolio
6.5.5 Kyowa Hakko Kirin Recent Developments/Updates
6.6 Shandong Kexing
6.6.1 Shandong Kexing Corporation Information
6.6.2 Shandong Kexing Description and Business Overview
6.6.3 Shandong Kexing rhEPO Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Shandong Kexing Product Portfolio
6.6.5 Shandong Kexing Recent Developments/Updates
6.7 Ahua Pharmaceutical
6.6.1 Ahua Pharmaceutical Corporation Information
6.6.2 Ahua Pharmaceutical Description and Business Overview
6.6.3 Ahua Pharmaceutical rhEPO Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Ahua Pharmaceutical Product Portfolio
6.7.5 Ahua Pharmaceutical Recent Developments/Updates
6.8 Biosidus
6.8.1 Biosidus Corporation Information
6.8.2 Biosidus Description and Business Overview
6.8.3 Biosidus rhEPO Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Biosidus Product Portfolio
6.8.5 Biosidus Recent Developments/Updates
6.9 Dragon Pharma
6.9.1 Dragon Pharma Corporation Information
6.9.2 Dragon Pharma Description and Business Overview
6.9.3 Dragon Pharma rhEPO Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Dragon Pharma Product Portfolio
6.9.5 Dragon Pharma Recent Developments/Updates

7 rhEPO Manufacturing Cost Analysis
7.1 rhEPO Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of rhEPO
7.4 rhEPO Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 rhEPO Distributors List
8.3 rhEPO Customers

9 rhEPO Market Dynamics
9.1 rhEPO Industry Trends
9.2 rhEPO Growth Drivers
9.3 rhEPO Market Challenges
9.4 rhEPO Market Restraints

10 Global Market Forecast
10.1 rhEPO Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of rhEPO by Type (2022-2027)
10.1.2 Global Forecasted Revenue of rhEPO by Type (2022-2027)
10.2 rhEPO Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of rhEPO by Application (2022-2027)
10.2.2 Global Forecasted Revenue of rhEPO by Application (2022-2027)
10.3 rhEPO Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of rhEPO by Region (2022-2027)
10.3.2 Global Forecasted Revenue of rhEPO by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables
Table 1. Global rhEPO Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global rhEPO Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global rhEPO Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers rhEPO Covered in This Study
Table 5. Global rhEPO Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global rhEPO Sales Share by Manufacturers (2016-2021)
Table 7. Global rhEPO Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global rhEPO Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market rhEPO Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers rhEPO Manufacturing Sites and Area Served
Table 11. Manufacturers rhEPO Product Type
Table 12. Global rhEPO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global rhEPO by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in rhEPO as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global rhEPO Sales by Region (2016-2021) & (K MT)
Table 16. Global rhEPO Sales Market Share by Region (2016-2021)
Table 17. Global rhEPO Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America rhEPO Sales by Country (2016-2021) & (K MT)
Table 19. North America rhEPO Sales Market Share by Country (2016-2021)
Table 20. North America rhEPO Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America rhEPO Revenue Market Share by Country (2016-2021)
Table 22. Europe rhEPO Sales by Country (2016-2021) & (K MT)
Table 23. Europe rhEPO Sales Market Share by Country (2016-2021)
Table 24. Europe rhEPO Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe rhEPO Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific rhEPO Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific rhEPO Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific rhEPO Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific rhEPO Revenue Market Share by Region (2016-2021)
Table 30. Latin America rhEPO Sales by Country (2016-2021) & (K MT)
Table 31. Latin America rhEPO Sales Market Share by Country (2016-2021)
Table 32. Latin America rhEPO Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America rhEPO Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa rhEPO Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa rhEPO Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa rhEPO Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa rhEPO Revenue Market Share by Country (2016-2021)
Table 38. Global rhEPO Sales (K MT) by Type (2016-2021)
Table 39. Global rhEPO Sales Market Share by Type (2016-2021)
Table 40. Global rhEPO Revenue (Million US$) by Type (2016-2021)
Table 41. Global rhEPO Revenue Share by Type (2016-2021)
Table 42. Global rhEPO Price (USD/MT) by Type (2016-2021)
Table 43. Global rhEPO Sales (K MT) by Application (2016-2021)
Table 44. Global rhEPO Sales Market Share by Application (2016-2021)
Table 45. Global rhEPO Revenue (Million US$) by Application (2016-2021)
Table 46. Global rhEPO Revenue Share by Application (2016-2021)
Table 47. Global rhEPO Price (USD/MT) by Application (2016-2021)
Table 48. 3SBio Corporation Information
Table 49. 3SBio Description and Business Overview
Table 50. 3SBio rhEPO Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. 3SBio rhEPO Product
Table 52. 3SBio Recent Developments/Updates
Table 53. Shanghai Chemo Corporation Information
Table 54. Shanghai Chemo Description and Business Overview
Table 55. Shanghai Chemo rhEPO Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Shanghai Chemo rhEPO Product
Table 57. Shanghai Chemo Recent Developments/Updates
Table 58. Chengdu Diao Corporation Information
Table 59. Chengdu Diao Description and Business Overview
Table 60. Chengdu Diao rhEPO Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Chengdu Diao rhEPO Product
Table 62. Chengdu Diao Recent Developments/Updates
Table 63. NCPC Genetech Corporation Information
Table 64. NCPC Genetech Description and Business Overview
Table 65. NCPC Genetech rhEPO Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. NCPC Genetech rhEPO Product
Table 67. NCPC Genetech Recent Developments/Updates
Table 68. Kyowa Hakko Kirin Corporation Information
Table 69. Kyowa Hakko Kirin Description and Business Overview
Table 70. Kyowa Hakko Kirin rhEPO Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Kyowa Hakko Kirin rhEPO Product
Table 72. Kyowa Hakko Kirin Recent Developments/Updates
Table 73. Shandong Kexing Corporation Information
Table 74. Shandong Kexing Description and Business Overview
Table 75. Shandong Kexing rhEPO Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Shandong Kexing rhEPO Product
Table 77. Shandong Kexing Recent Developments/Updates
Table 78. Ahua Pharmaceutical Corporation Information
Table 79. Ahua Pharmaceutical Description and Business Overview
Table 80. Ahua Pharmaceutical rhEPO Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. Ahua Pharmaceutical rhEPO Product
Table 82. Ahua Pharmaceutical Recent Developments/Updates
Table 83. Biosidus Corporation Information
Table 84. Biosidus Description and Business Overview
Table 85. Biosidus rhEPO Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. Biosidus rhEPO Product
Table 87. Biosidus Recent Developments/Updates
Table 88. Dragon Pharma Corporation Information
Table 89. Dragon Pharma Description and Business Overview
Table 90. Dragon Pharma rhEPO Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. Dragon Pharma rhEPO Product
Table 92. Dragon Pharma Recent Developments/Updates
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. rhEPO Distributors List
Table 96. rhEPO Customers List
Table 97. rhEPO Market Trends
Table 98. rhEPO Growth Drivers
Table 99. rhEPO Market Restraints
Table 100. Global rhEPO Sales Forecast by Type (2022-2027) & (K MT)
Table 101. Global rhEPO Sales Market Share Forecast by Type (2022-2027)
Table 102. Global rhEPO Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 103. Global rhEPO Revenue Market Share Forecast by Type (2022-2027)
Table 104. Global rhEPO Sales Forecast by Application (2022-2027) & (K MT)
Table 105. Global rhEPO Sales Market Share Forecast by Application (2022-2027)
Table 106. Global rhEPO Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 107. Global rhEPO Revenue Market Share Forecast by Application (2022-2027)
Table 108. Global rhEPO Sales Forecast by Region (2022-2027) & (K MT)
Table 109. Global rhEPO Sales Market Share Forecast by Region (2022-2027)
Table 110. Global rhEPO Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 111. Global rhEPO Revenue Market Share Forecast by Region (2022-2027)
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of rhEPO
Figure 2. Global rhEPO Market Share by Type in 2020 & 2027
Figure 3. ESRD Product Picture
Figure 4. Cancer Product Picture
Figure 5. HIV Product Picture
Figure 6. Wounds and neural disease Product Picture
Figure 7. Global rhEPO Market Share by Application in 2020 & 2027
Figure 8. Hospitals
Figure 9. Retail Pharmacies
Figure 10. Global rhEPO Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global rhEPO Market Size 2016-2027 (US$ Million)
Figure 12. Global rhEPO Sales 2016-2027 (K MT)
Figure 13. Global rhEPO Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. rhEPO Sales Share by Manufacturers in 2020
Figure 15. Global rhEPO Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest rhEPO Players: Market Share by Revenue in 2020
Figure 17. rhEPO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global rhEPO Sales Market Share by Region (2016-2021)
Figure 19. Global rhEPO Sales Market Share by Region in 2020
Figure 20. Global rhEPO Revenue Market Share by Region (2016-2021)
Figure 21. Global rhEPO Revenue Market Share by Region in 2020
Figure 22. United States rhEPO Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada rhEPO Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Mexico rhEPO Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany rhEPO Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France rhEPO Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. UK rhEPO Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy rhEPO Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia rhEPO Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China rhEPO Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan rhEPO Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea rhEPO Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India rhEPO Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia rhEPO Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia rhEPO Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand rhEPO Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia rhEPO Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines rhEPO Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam rhEPO Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil rhEPO Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey rhEPO Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. GCC Countries rhEPO Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Egypt rhEPO Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. South Africa rhEPO Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of rhEPO by Type (2016-2021)
Figure 46. Sales Market Share of rhEPO by Application (2016-2021)
Figure 47. Sales Market Share of rhEPO by Application in 2020
Figure 48. Revenue Share of rhEPO by Application (2016-2021)
Figure 49. Revenue Share of rhEPO by Application in 2020
Figure 50. Manufacturing Cost Structure of rhEPO
Figure 51. Manufacturing Process Analysis of rhEPO
Figure 52. rhEPO Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.